Skip to Main Content

Paper Details

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.
Breast Cancer Res Treat
16
2017
11q22, 175 genes, ACAT1, ATM, BRCA1, BRCA1 mutation, BRCA1/2, BRCA2, BRCA2 mutation, Cis-acting regulatory SNPs, ER, HER2, NPAT, SNPs, breast and ovarian cancer, breast cancer, cancer, complex diseases, estrogen, estrogen receptor, genetic variants, locus 11q22, mammary cell, modifier, progesterone, progesterone receptor, risk-associated SNPs, rs228595, triple, tumors
Author NameAffiliation
Tomi PastinenMcGill University
Tomi PastinenMcGill University and Genome Quebec Innovation Centre
Arnaud DroitCentre Hospitalier Universitaire de Quebec Research Center and Laval University
Irene L AndrulisLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Irene L AndrulisLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Javier Ben??tezSpanish National Cancer Centre (CNIO)
Javier Ben??tez
Javier Ben??tezSpanish National Cancer Research Centre (CNIO)
Wendy K ChungColumbia University
Wendy K ChungColumbia University
Susan M DomchekAbramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
Rosalind A EelesThe Institute of Cancer Research and Royal Marsden NHS Foundation Trust
William D FoulkesMcGill University
William D FoulkesMcGill University
Judy E GarberCancer Risk and Prevention Clinic, Dana-Farber Cancer Institute
Simon A GaytherKeck School of Medicine, University of Southern California
David E GoldgarUniversity of Utah School of Medicine
David E GoldgarUniversity of Utah School of Medicine
Jacek GronwaldPomeranian Medical University
Jacek GronwaldPomeranian Medical University
Peter J HulickCenter for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine
Peter J HulickCenter for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine
Claudine IsaacsLombardi Comprehensive Cancer Center, Georgetown University
Louise IzattClinical Genetics, Guy's and St. Thomas' NHS Foundation Trust
Esther M JohnCancer Prevention Institute of California
Esther M JohnDepartment of Health Research and Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine
Beth Y KarlanWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Judy KirkWestmead Hospital
Jenny LesterWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Siranoush ManoukianFondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT)
Katherine L NathansonAbramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
Robert L NussbaumUniversity of California san francisco
Ana OsorioSpanish National Cancer Centre (CNIO)
Ana Osorio
Paolo RadiceFondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT)
Andrea L RichardsonJohns Hopkins University School of Medicine
Gustavo C RodriguezNorthShore University HealthSystem, University of Chicago
Amanda B SpurdleQIMR Berghofer Medical Research Institute
Amanda B SpurdleQIMR Berghofer Medical Research Institute
Mary Beth TerryColumbia University
Timothy R RebbeckAbramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
Timothy R RebbeckCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
  • 1 - 50

Datasets